CABA
Income statement / Annual
Last year (2024), Cabaletta Bio, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Cabaletta Bio, Inc.'s net income was -$115.86 M.
See Cabaletta Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$4.81 M
|
$1.43 M
|
$3.68 M
|
$733.00 K
|
$354.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
-$4.81 M
|
-$1.43 M
|
-$3.68 M
|
-$733.00 K
|
-$354.00 K
|
-$104.00 K
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$97.20 M
|
$55.42 M
|
$39.30 M
|
$32.49 M
|
$21.38 M
|
$11.67 M
|
$4.47 M
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$19.24 M
|
$0.00
|
$0.00
|
$0.00
|
$7.01 M
|
$1.73 M
|
$333.33 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$23.13 M
|
$19.24 M
|
$11.16 M
|
$13.09 M
|
$12.10 M
|
$7.01 M
|
$1.73 M
|
$250.00 K
|
| Other Expenses |
$0.00
|
-$1.43 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$120.33 M
|
$73.23 M
|
$50.46 M
|
$45.58 M
|
$33.48 M
|
$18.68 M
|
$6.19 M
|
$250.00 K
|
| Cost And Expenses |
$125.14 M
|
$74.66 M
|
$54.14 M
|
$46.31 M
|
$33.83 M
|
$18.68 M
|
$6.19 M
|
$333.33 K
|
| Interest Income |
$10.03 M
|
$6.99 M
|
$1.16 M
|
$24.00 K
|
$494.00 K
|
$1.74 M
|
$235.00 K
|
$0.00
|
| Interest Expense |
$748.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$4.81 M
|
$1.43 M
|
$3.68 M
|
$733.00 K
|
$354.00 K
|
$104.00 K
|
$6.19 M
|
$333.33 K
|
| EBITDA |
-$110.30 M |
-$66.25 M |
-$49.29 M |
-$45.56 M |
-$32.99 M |
-$18.58 M |
-$6.01 M |
$83.33 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$9.28 M
|
$6.99 M
|
$1.16 M
|
$24.00 K
|
$494.00 K
|
$1.74 M
|
-$6.01 M
|
$0.00
|
| Income Before Tax |
-$115.86 M
|
-$67.68 M
|
-$52.98 M
|
-$46.29 M
|
-$33.34 M
|
-$16.94 M
|
-$12.20 M
|
-$250.00 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$115.86 M
|
-$67.68 M
|
-$52.98 M
|
-$46.29 M
|
-$33.34 M
|
-$16.94 M
|
-$12.20 M
|
-$250.00 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-2.34 |
-1.65 |
-1.81 |
-1.8 |
-1.44 |
-4.07 |
-0.84 |
-0.0104 |
| EPS Diluted |
-2.34 |
-1.65 |
-1.81 |
-1.8 |
-1.44 |
-4.07 |
-0.84 |
-0.0104 |
| Weighted Average Shares Out |
$49.52 M
|
$40.95 M
|
$29.34 M
|
$25.74 M
|
$23.15 M
|
$4.16 M
|
$14.51 M
|
$24.03 M
|
| Weighted Average Shares Out Diluted |
$49.47 M
|
$40.95 M
|
$29.34 M
|
$25.74 M
|
$23.15 M
|
$5.47 M
|
$14.51 M
|
$24.03 M
|
| Link |
|
|
|
|
|
|
|
|
